Epitalon (Epithalon)
PeptideThe large discrepancy arises because users in biohacking communities report subjective improvements in sleep and mood [c1, c2, c3], while the medical evidence is based exclusively on in vitro and animal data, with no single RCT in humans [s11, s12]. Community experiences may be confounded by placebo effects and publication bias in forums [s14].
Unlock full information
Dosages, side effects, studies and more — free after registration.
Register for freeRating Scales
TL;DR
Epitalon is a synthetic tetrapeptide whose telomerase-activating effects have only been demonstrated in cell cultures and animal models — independent replication is absent, and virtually all human data originates from a single Russian research group. The theoretical oncological risk from telomerase activation is real and underappreciated in community discussions. The most consistent user-reported benefit is improved sleep; everything else remains speculative. Product purity from commercial suppliers is a serious, recurring concern.
Description
Synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from the pineal gland; investigated in animal models and in vitro studies for telomerase activation, lifespan extension, and tumor suppression [s1, s2, s3].
Epitalon (also: Epithalon) is a synthetic tetrapeptide with the amino acid sequence alanine–glutamic acid–aspartic acid–glycine (Ala-Glu-Asp-Gly). It was isolated and chemically characterized by Russian gerontologist Vladimir Khavinson from the pineal gland extract Epithalamin [s5, s6]. Scientific attention focuses primarily on three areas: (1) Telomere biology: Cell culture studies using human fetal fibroblasts demonstrated that Epitalon induces expression of the catalytic subunit of telomerase (hTERT), increases telomerase activity, and extends telomere length [s1, s2]. Treated cells exceeded the Hayflick limit and divided beyond 44 passages, compared to 34 passages in controls [s2]. (2) Animal studies: In mice and rats, extended maximum lifespan of approximately 12–13%, reduced chromosomal damage, and significantly lower leukemia incidence were observed [s3, s4]. Suppression of colon carcinogenesis induced by 1,2-dimethylhydrazine and inhibition of mammary carcinogenesis have been documented in rodents [s7, s8]. (3) Melatonin and circadian regulation: Clinical observational studies in elderly individuals demonstrated normalization of the circadian melatonin rhythm following Epithalamin treatment [s9, s10]. No randomized, placebo-controlled double-blind trials (RCTs) exist for Epitalon in humans. Available human studies are small, methodologically weak, and originate predominantly from Russian institutions without independent replication [s11, s12]. Medscape and other regulatory authorities explicitly caution against its use due to insufficient safety data [s14].
Legal Status (DE)
{'note': 'No official BfArM document, no AMG reference, and no EMA decision regarding Epitalon found in searchable sources. Classification as a "research chemical" (AMG § 2) continues to rely on secondary inferences from NCATS [s13] and Medscape [s14], not on a primary German regulatory source. A BfArM or EMA primary source should be added when available. Until then: classification is marked as not officially verified by a regulatory authority. ', 'authoritative_german_source': None}
Mechanism of Action
Epitalon acts via several hypothetical mechanisms investigated primarily in cell cultures and animal models: 1. Telomerase activation [s1, s2]: The peptide induces expression of the catalytic subunit hTERT in primary human fibroblasts, resulting in measurable telomere elongation. This effect was demonstrated in telomerase-negative cells and has not yet been replicated in living humans. 2. Epigenetic chromatin modulation [s13]: Epitalon is proposed to reverse age-related condensation of heterochromatin near centromeres, rendering previously repressed genes accessible. This mechanism is based on in vitro data from human lymphocytes of donors aged 76–80 years. 3. Pineal gland and melatonin regulation [s9, s10]: In observational studies in elderly humans and primates, Epithalamin (the crude extract from which Epitalon was isolated) normalized the nocturnal melatonin profile. The precise mechanism for the synthetic tetrapeptide remains unclear. 4. Antioxidant effects and oxidative stress [s5]: Reduced markers of oxidative stress have been described in animal models, which could indirectly contribute to telomere stabilization. 5. Tumor suppression [s7, s8]: Antiproliferative effects were observed in rodents, possibly via modulation of MMP9 (inhibition in aging dermal fibroblasts in vitro) and pro-apoptotic signaling pathways. None of the aforementioned mechanisms have been confirmed in human RCTs.
Calculate reconstitution, plan dosing, look up injection technique
Side Effects
| Side Effect | Frequency | Severity |
|---|---|---|
| Reaktionen an der Injektionsstelle (Schmerzen, Rötung, Schwellung) Typical local reaction to subcutaneous peptide injections; described in clinical observational studies [s11, s16]. | gelegentlich | leicht |
| Vorübergehende Müdigkeit Reported sporadically by users, possibly related to the melatonin-regulating effect [s15, c1]. | selten | leicht |
| Kopfschmerzen Described in very rare cases following Epitalon administration; no clinical study systematically documents this [s16]. | selten | leicht |
| Immunogenität durch verunreinigte Peptidpräparate Research chemicals are not subject to pharmaceutical quality control; contaminants can trigger immunogenic reactions [s14]. | theoretisch | schwer |
| Unbekannte Langzeitrisiken (inkl. theoretisches onkologisches Risiko durch Telomerase-Aktivierung) Telomerase activation is a well-established mechanism in carcinogenesis. Although animal studies generally demonstrated tumor suppression [s7, s8], long-term risk in humans is entirely unknown. A 2025 systematic review explicitly highlights the absence of safety data [s12]. | theoretisch | schwer |
Contraindications
Telomerase activation is a central mechanism of cancer cell proliferation. Although animal data show tumor suppression, a pro-tumorigenic effect in human cancer patients cannot be theoretically excluded [s7, s8, s12].
No safety data available for pregnancy or lactation. Effects on embryonic and fetal development are entirely unknown [s12].
Epigenetic chromatin modulation and immune recalibration could theoretically influence autoimmune processes; no clinical data available [s13].
No pediatric safety data available. Effects on natural growth and maturation processes are entirely unknown [s12].
Interactions
Synergistic
Both substances modulate circadian rhythmicity via the pineal gland; additive effect on melatonin normalization is theoretically plausible but not clinically established [s9, s10].
Epitalon and BPC-157 are combined in regenerative peptide stacks as they cover complementary mechanisms – Epitalon acts at the cellular level via telomerase activation, while BPC-157 promotes tissue healing and reduces inflammation. Clinical data are currently lacking.
The combination of Epitalon and GHK-Cu targets different levels of cellular aging – Epitalon elongates telomeres in the cell nucleus, while GHK-Cu modulates the extracellular matrix and gene expression. A synergistic effect on skin regeneration and cellular longevity is theoretically discussed.
Epitalon and TB-500 are combined in regenerative stacks, as TB-500 promotes tissue repair and anti-inflammation, while Epitalon targets cellular longevity. Both peptides theoretically complement each other in regeneration.
Epitalon combined with CJC-1295/Ipamorelin is purported to support growth hormone secretion and recovery, while Epitalon regenerates the pineal gland and normalizes melatonin production. The combination is popular in anti-aging stacks; however, clinical evidence is lacking.
Ipamorelin is frequently stacked with CJC-1295 and Epitalon to maximize GH release while simultaneously promoting cellular longevity. The combination is widespread in biohacker circles but is not clinically substantiated.
Epitalon and DHEA are combined in anti-aging stacks as both address age-related hormonal changes – Epitalon via pineal gland regulation, DHEA as a precursor hormone to sex hormones. Clinical data on the combination are lacking.
Ashwagandha (e.g., as part of a sleep-recovery stack with magnesium and zinc) is combined with Epitalon to optimize circadian rhythm, stress hormone balance, and sleep quality. Both substances modulate cortisol and support hormonal balance; clinical synergy data are lacking.
Fisetin as a senolytic agent could complement Epitalon in combating cellular senescence – Fisetin eliminates senescent cells while Epitalon preserves telomere length. The combination is theoretically discussed; clinical data are lacking.
Quercetin as a senolytic and antioxidant could complement Epitalon in a cellular anti-aging strategy by clearing senescent cells while Epitalon protects telomeres. A synergistic effect is mechanistically plausible but not clinically established.
Caution
Theoretical immunomodulation by Epitalon could influence the effect of immunosuppressants; no clinical data available [s13].
Telomerase activation by Epithalon is potentially counterproductive in cancer treatments aimed at inhibiting telomerase or suppressing tumor cell proliferation [s7, s8, s12].
Studies
Tier B — Moderate Evidence
Community Evidence
Top reported benefits
- Improved sleep quality within 1–2 weeks
- Better mood and reduced brain fog
- Subjectively increased energy levels in the afternoon
- Faster recovery (anecdotal)
Top reported issues
- Many users report no noticeable effects
- Telomere elongation is not subjectively perceptible
- Uncertainty regarding dosage and protocol
- Quality concerns with research chemical sources
Several skeptical voices in r/Peptides note that the key studies have not been independently replicated and originate almost exclusively from a single Russian research group (Khavinson) [c4]. The distinction between Epithalamin (crude extract) and synthetic Epitalon is frequently not made correctly in community discussions [c1, c3]. Product quality and purity of commercial suppliers are a recurring concern [c5].
Scientific Sources
- Epitalon increases telomere length in human cell lines (PMC Article)
Khavinson VKh, et al. (2003). Bulletin of Experimental Biology and MedicineCPMID:12937682DOI - Normalizing effect of the pineal gland peptides on the daily melatonin rhythm in old monkeys and elderly people
Goncharova ND, Khavinson VKh, Lapin BA (2007). Neuroendocrinology LettersBPMID:17969590 - Clinical observation trial: safety of Epitalon in elderly patients (162 patients, 2002 – cited in Innerbody review)
Khavinson VKh, et al. (2002). Russian clinical gerontology literature (unverified primary source)CLink - Epitalon Peptide: What It Is and How It Works (Innerbody Review citing 2025 systematic review on safety gaps)
Innerbody Research / Innerbody editorial team (2025). Innerbody Research (citing independent 2025 systematic review)BLink - NCATS Inxight Drugs — EPITALON: epigenetic and chromatin remodeling mechanisms
NCATS (National Center for Advancing Translational Sciences) (2024). NCATS Inxight Drugs DatabaseBLink - Wellness Peptides Lack Reliable Safety Information, Watchdog Warns
Medscape editorial team (2026). MedscapeBLink - Epitalon Dosing: 10 mg/Day for 10 Days, Then Stop – The Peptide Catalog
The Peptide Catalog editorial team (2024). The Peptide Catalog (non-peer-reviewed)DLink - Epitalon-Peptid verstehen: Dosierung, Sicherheit und Anwendung im Wellness-Bereich
nbinno editorial team (2024). nbinno.com (nicht begutachtet)DLink - Peptide Epitalon activates chromatin at the old age
Khavinson VKh, Lezhava TA, Monaselidze JR, Jokhadze TA, Dvalishvili NA, Bablishvili NK, Trofimova SV (2003). Neuroendocrinology LettersBLink - Overview of Epitalon — Highly bioactive pineal tetrapeptide with promising properties
Kossoy G et al. (2025). International Journal of Molecular SciencesBDOI - Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells
Khavinson VKh, Bondarev IE, Butyugov AA (2003). Bulletin of Experimental Biology and MedicineCPMID:12937682 - Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice
Anisimov VN, Khavinson VKh, Morozov VG (2003). BiogerontologyCDOI - Effect of epitalon on the life span increase in Drosophila melanogaster
Khavinson VKh, Razumovsky MI, Trofimova SV, et al. (2000). Mechanisms of Ageing and DevelopmentCLink - Morphofunctional and molecular bases of pineal gland aging
Khavinson VKh, Linkova NS, Kvetnoy IM, et al. (2012). Human PhysiologyBDOI - Epitalon – Wikipedia
Wikipedia contributors (2024). WikipediaDLink - Inhibitory effect of peptide Epitalon on colon carcinogenesis induced by 1,2-dimethylhydrazine in rats
Anisimov VN, Khavinson VKh, Provinciali M, et al. (2002). Cancer LettersCDOI - Epitalon and cancer: potent inhibitors of mammary carcinogenesis in rodents (review/preclinical evidence)
Anisimov VN, Khavinson VKh, et al. (2004). Neoplasma / World of Peptides (review)CLink - Effect of peptide preparation epithalamin on circadian rhythm of epiphyseal melatonin-producing function in elderly people
Korkushko OV, Khavinson VKh, Shatilo VB, et al. (2004). Bulletin of Experimental Biology and MedicineBPMID:15452611
Community Sources
Storage
Unopened
Store lyophilized powder at -20 °C, protected from light.
Opened
After reconstitution with bacteriostatic water, store at 2–8 °C (refrigerator); use within 4–6 weeks.
Notes
No pharmaceutical stability studies available for commercially available research preparations. Information is based on general peptide storage recommendations.